Ligand validation:6HXK

FLC: CITRATE ANION

FLC is a Ligand Of Interest in 6HXK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HXK_FLC_A_1200	48%	51%	0.152	0.897	0.36	1.52	-	1	0	0	100%	0.63
6HXK_FLC_C_1202	44%	75%	0.17	0.897	0.49	0.47	-	-	0	0	100%	1
6HXK_FLC_B_1201	24%	73%	0.195	0.825	0.54	0.49	-	-	0	0	100%	1
6HXK_FLC_D_1200	8%	29%	0.266	0.747	0.4	2.51	-	1	0	0	100%	0.39
6HXL_FLC_B_1202	96%	22%	0.066	0.973	0.98	2.38	-	5	0	0	100%	1
6HXM_FLC_A_1201	93%	46%	0.062	0.957	0.63	1.45	-	1	1	0	100%	1
3GNE_FLC_B_502	100%	35%	0.04	0.995	1.08	1.59	1	3	0	0	100%	1
4X84_FLC_C_300	99%	45%	0.045	0.985	1.36	0.81	1	-	0	0	100%	1
3M1X_FLC_A_128	99%	24%	0.051	0.985	1.53	1.71	2	5	1	0	100%	1
1S6A_FLC_A_227	99%	39%	0.051	0.983	1.14	1.29	1	2	0	0	100%	1
2IY6_FLC_B_1517	99%	40%	0.054	0.986	1.11	1.3	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.